Apr 30, 2019 07:00AM
Feb 13, 2019 07:00AM
Feb 7, 2019 07:00AM
Feb 5, 2019 07:00AM
Nov 16, 2018 07:30AM
Nov 13, 2018 04:01PM
Nov 6, 2018 07:00AM Imprimis Pharmaceuticals to Announce Third Quarter 2018 Financial Results on November 13, 2018
Oct 23, 2018 07:08AM
Oct 23, 2018 07:00AM
Oct 16, 2018 07:00AM
Aug 6, 2018 04:01PM
Aug 1, 2018 07:30AM
Jul 31, 2018 07:30AM
Jul 18, 2018 07:30AM Imprimis Pharmaceuticals to Present at the Canaccord Genuity 38th Annual Growth Conference on August 9, 2018
May 30, 2018 07:30AM
May 15, 2018 04:01PM
May 15, 2018 07:32AM
May 15, 2018 07:30AM
May 2, 2018 07:30AM
May 2, 2018 07:30AM
Apr 10, 2018 07:30AM Imprimis Pharmaceuticals to feature its patent-pending cyclosporine/chondroitin sulfate and patented non-opioid MKO Melt® (midazolam/ketamine/ondansetron) formulations at the upcoming Cataract &
Mar 27, 2018 07:34AM
Mar 27, 2018 07:30AM
Mar 8, 2018 04:01PM
Mar 7, 2018 07:30AM
Mar 6, 2018 07:30AM
Feb 15, 2018 07:30AM
Jan 30, 2018 08:16AM Imprimis Pharma (IMMY) Says It's Making Available Two Glaucoma Drugs on FDA's Drug Shortage List
Jan 30, 2018 07:30AM
Jan 24, 2018 07:30AM
Oct 24, 2017 07:30AM
Oct 19, 2017 11:29PM
Oct 19, 2017 07:30AM
Oct 2, 2017 07:30AM
Sep 14, 2017 08:07AM Imprimis Pharma (IMMY) Says FDA Curcumin Investigation Supports its Statement
Sep 14, 2017 08:00AM
Sep 11, 2017 07:36AM
Sep 11, 2017 07:30AM
Aug 10, 2017 04:01PM
Aug 7, 2017 08:06AM
Aug 7, 2017 08:00AM
Aug 4, 2017 03:15PM FDA Investigation Reports Two Serious Adverse Events Associated with ImprimisRx's (IMMY) Compounded Curcumin Emulsion Product for Injection
Jul 27, 2017 08:00AM
Jun 23, 2017 08:02AM
Jun 23, 2017 08:00AM
Jun 20, 2017 04:01PM
May 10, 2017 04:01PM
May 4, 2017 08:30AM
Apr 18, 2017 08:33AM Imprimis Pharma (IMMY) Signs Agreement with Precision Less to Expand Imprimis' Ophthalmic Portfolio Market Opportunity in the U.S. Midwest
Apr 18, 2017 08:30AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All